 ?您的位置：對照品 > 標(biāo)準品 > 農(nóng)藥標(biāo)準品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：F596168 |
| 產(chǎn)品名稱：2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(pheny |
| 產(chǎn)品CAS：1391194-36-7 |
| 規(guī)格含量：1mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標(biāo)準品編號: |
F596168 |
| 名稱: |
2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid |
| CAS號: |
1391194-36-7 |
| 分子式: |
C??H??FN?O? |
| 分子量: |
556.62 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid is an intermediate useful in the synthesis of rac-3-Oxo Atorvastatin Sodium Salt (O847150), which is a byproduct impurity of Atorvastatin Calcium (A791750), a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglyceinhibitorrides in patients with hypercholesterolemia. |
| 參考文獻 |
|
|
|
|
|
|
